Millstone Evans Group LLC Takes Position in The Clorox Company (NYSE:CLX)

Millstone Evans Group LLC bought a new stake in The Clorox Company (NYSE:CLXFree Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 191 shares of the company’s stock, valued at approximately $31,000.

Several other institutional investors and hedge funds have also bought and sold shares of CLX. iA Global Asset Management Inc. acquired a new stake in shares of Clorox in the 4th quarter valued at approximately $2,768,000. Fiduciary Group LLC raised its position in Clorox by 4.8% during the fourth quarter. Fiduciary Group LLC now owns 20,374 shares of the company’s stock worth $3,309,000 after acquiring an additional 935 shares in the last quarter. Vinva Investment Management Ltd lifted its stake in Clorox by 147.7% in the fourth quarter. Vinva Investment Management Ltd now owns 6,627 shares of the company’s stock valued at $1,070,000 after acquiring an additional 3,952 shares during the last quarter. Enhancing Capital LLC acquired a new position in shares of Clorox during the 4th quarter worth about $325,000. Finally, Intech Investment Management LLC raised its holdings in shares of Clorox by 91.9% in the 4th quarter. Intech Investment Management LLC now owns 54,428 shares of the company’s stock valued at $8,840,000 after purchasing an additional 26,058 shares during the period. Institutional investors own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the topic of several research analyst reports. Wells Fargo & Company upped their price objective on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. DA Davidson reduced their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Barclays increased their price objective on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. JPMorgan Chase & Co. increased their target price on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company. According to data from MarketBeat, Clorox has a consensus rating of “Hold” and a consensus price target of $159.62.

View Our Latest Report on CLX

Clorox Stock Down 0.8 %

Shares of Clorox stock opened at $143.75 on Tuesday. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The firm has a market cap of $17.71 billion, a price-to-earnings ratio of 39.28, a PEG ratio of 2.62 and a beta of 0.45. The stock’s 50-day moving average is $152.57 and its 200 day moving average is $159.59. The Clorox Company has a one year low of $127.60 and a one year high of $171.37.

Clorox (NYSE:CLXGet Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the firm earned $2.16 earnings per share. Equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.39%. The ex-dividend date is Wednesday, April 23rd. Clorox’s payout ratio is 133.33%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.